FDA Clearance Tracker · K243808
Rayvolve PTX-PE
Last checked: Nov 20, 2026Latest source record: Mar 21, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Mar 21, 2025
Substantially Equivalent
Time to decision
100 days
Received Dec 11, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K243808
- Device name
- Rayvolve PTX-PE
- Applicant
- AZmed
- Applicant location
- Paris, FR
- Received
- Dec 11, 2024
- Decided
- Mar 21, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 892.2080
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code QFM. The earliest in FDA's data is K183285, decided Mar 8, 2019.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K243808
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for AZmed
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Rayvolve AZchest510(k)
K261378 · Decided Aug 28, 2026 · 123 days after receipt
Device type: Radiological Computer Assisted Detection/Diagnosis Software For Fracture (QBS) · Radiology & Imaging
- Rayvolve510(k)
K260378 · Decided May 12, 2026 · 96 days after receipt
Device type: Radiological Computer Assisted Detection/Diagnosis Software For Fracture (QBS) · Radiology & Imaging
- Rayvolve LN510(k)
K243831 · Decided Mar 26, 2025 · 103 days after receipt
Device type: Analyzer, Medical Image (MYN) · Radiology & Imaging
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.